Form 4 for EW Edwards Lifesciences
Accepted 2022-05-26 00:00:00 ET · period of report 2022-05-26 · accession 0001225208-22-007410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-26 | 2022-05-26 | EW | Chopra Daveen | CVP, Surgical Structural Heart | S - Sale | $98.31 | -1,000 | 19.9K | -5% | -$98.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-26 | S | D | 1,000 | $98.31 | 19,911 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $98.295 to $98.370. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |